I was a bit disappointed with the conference today. A little sobering with Prurisol anticipated approval almost four years away. I expected they would submit NDA some time in 2018 rather than the end of 2019. I would have bet the farm we would be approved for market in 2019.

As for the near term, a great report on B-UP cohort two or blowout P2B interim results could get us moving. I'm now hesitant that we will have a partnership signed in 2017. From what I understand these deals can take several months to make it through legal so even if a BP (thinking Pfizer) says “Deal!” on interim Prurisol results I'm curious if it can actually be inked swiftly or if this is likely a year end event. I'll go out on a limb and predict that we will fund all operations through June 30, 2017 (the full amount required per the last 10-K) using Aspire. I believe it has been a factor throughout Summer/Fall and will continue being an overhang on the stock through Winter/Spring. Hopefully new buyers on results will chew through the supply with ease. I welcome this being thrown back in my face when the new 10-K is provided in September if I'm wrong.

I've shifted my hopes from partnerships on all platforms to a single quick partnership followed by a full buyout after all the B/K phase 2s are in. Give us a fast 2-3 billion and let BP divide up the spoils. 2020 brings the risk of a hard swing to leftist government and drug price controls. We're also likely to have a heavy market/bubble correction at some point between now and then. Forget the royalties and give me the cash upfront! I'm hoping the Trumpster can help Pfizer get the buyout money here quickly and efficiently.

I am considering buying more shortly (no, not covering you silly geese) but I may just hold and see how the market likes the early Trump days.